Deep Brain Stimulation In Parkinson`s Disease Market Size Projected To Increase From $3.49 Billion To $4.49 Billion During The Forecast Period
Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Deep Brain Stimulation In Parkinson`s Disease Market Value Expansion And Long-Term Growth Outlook
The deep brain stimulation in parkinson’s disease market has experienced robust expansion over recent years. This market is projected to expand from $3.27 billion in 2025 to reach $3.49 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 6.7%. Historically, this market’s upward trend has stemmed from factors such as the rising incidence of Parkinson’s disease, greater acceptance of DBS devices, enhanced understanding of sophisticated neuromodulation treatments, improvements in neurosurgical facilities, and an increase in expenditure on healthcare.
The deep brain stimulation in parkinson’s disease market is projected to experience robust expansion over the coming years. It is anticipated to reach $4.49 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.4%. This projected growth during the forecast timeframe is attributable to several factors, including an escalating demand for customized neuromodulation treatments, increased capital allocated to research and clinical studies, improved availability of tele-neurology services, broader reimbursement options, and the growing uptake of MRI-safe and rechargeable equipment. Key trends expected during this period encompass technological progress in both closed-loop and directional stimulation, novel developments in rechargeable and extended-life Implantable Pulse Generators (IPGs), advancements in AI-supported DBS programming, ongoing research and development into less invasive surgical methods, and enhancements in remote patient monitoring and telemedicine functionalities.
Download A Free Sample Report For Comprehensive Market Insights:
Deep Brain Stimulation In Parkinson`s Disease Market Opportunity Drivers: What Is Creating New Revenue Potential?
The increasing number of individuals affected by Parkinson’s disease is poised to stimulate the expansion of the deep brain stimulation in Parkinson’s disease market. Parkinson’s disease is a progressive neurological condition impacting movement, characterized by symptoms like tremors, stiffness, slowed movements, and impaired balance due to the deterioration of dopamine-producing neurons in the brain. The growth in Parkinson’s disease patient numbers is linked to the aging global population, as the risk of developing the disorder rises significantly with age. Deep brain stimulation assists in managing Parkinson’s disease by delivering precise electrical impulses to specific brain areas, which helps diminish motor symptoms, improve life quality, and reduce the need for long-term medication. For instance, the Parkinson’s Foundation estimated that 1.1 million people in the United States were living with Parkinson’s disease in 2025, a number expected to climb to 1.2 million by 2030, with approximately 90,000 new diagnoses occurring annually and over 10 million individuals affected worldwide. Therefore, the escalating prevalence of Parkinson’s disease patients is a primary catalyst for the growth of the deep brain stimulation in Parkinson’s disease market. Rising healthcare expenditure is anticipated to drive the growth of the deep brain stimulation in Parkinson’s disease market moving forward. Healthcare expenditure denotes the total financial investment from governments, businesses, and individuals into healthcare services, covering medical treatments, hospital care, pharmaceuticals, and public health programs. The increased demand for healthcare funding stems from the growing incidence of chronic diseases, which demand extensive and costly long-term treatments. Elevated healthcare expenditure facilitates deep brain stimulation in Parkinson’s disease by providing financial backing for advanced surgical procedures, essential equipment, and subsequent care. This funding enhances patient outcomes by improving access to this effective therapy, which works to alleviate motor symptoms and elevate quality of life. For example, in May 2024, the Office for National Statistics reported that total healthcare expenditure experienced a 5.6% increase in nominal terms in 2023, showing a 0.9% growth compared to 2022. Consequently, the increasing healthcare expenditure is fueling the expansion of the deep brain stimulation in Parkinson’s disease market.
Deep Brain Stimulation In Parkinson`s Disease Market Segment Breakdown: Which Categories Generate The Most Revenue?
The deep brain stimulation in parkinson`s disease market covered in this report is segmented –
1) By Product Type: Implantable Pulse Generators (IPGs), Electrodes And Leads, External Programmers, Accessories And Consumables
2) By Technology: Conventional Deep Brain Stimulation (DBS) Systems, Closed Loop Deep Brain Stimulation (DBS) Systems, Wireless Deep Brain Stimulation (DBS) Systems
3) By Service Type: Pre-Surgical Evaluation Services, Surgical Implantation Services, Device Programming Services, Patient Monitoring Services, Maintenance And Follow-Up Services, Rehabilitation Support Services, Tele-Neurology Support Services, Training And Education Services
4) By Application: Tremor Management, Rigidity And Stiffness Management, Bradykinesia (Slow Movement) Management, Dyskinesia Management
5) By End-Users: Hospitals, Ambulatory Surgical Centres, Neurology Clinics
Subsegments:
1) By Implantable Pulse Generators (IPGs): Rechargeable Implantable Pulse Generators, Non-Rechargeable Implantable Pulse Generators, Directional Implantable Pulse Generators
2) By Electrodes And Leads: Cylindrical Electrodes, Directional Electrodes, Stimulation Leads
3) By External Programmers: Handheld External Programmers, Desktop External Programmers, Wireless External Programmers
4) By Accessories And Consumables: Extension Cables, Battery Chargers, Surgical Tool Kits
Deep Brain Stimulation In Parkinson`s Disease Market Innovation Trends Driving Future Development
Major companies operating in the deep brain stimulation in Parkinson’s disease market are prioritizing the creation of advanced products, including miniaturized rechargeable implantable pulse generators and integrated remote programming platforms, to enhance patient comfort and improve access to care. Miniaturizing rechargeable implantable pulse generators involves designing these battery-powered neurostimulation devices in much smaller, thinner forms for less invasive implantation, while still providing reliable therapeutic electrical pulses for long durations. For instance, in January 2024, Abbott Laboratories, a US-based multinational medical devices and healthcare company, launched its Liberta RC DBS system. This platform is a miniaturized rechargeable deep brain stimulation system featuring remote programming capabilities, developed to treat individuals with movement disorders such as Parkinson’s disease and essential tremor. The solution also delivers the longest recharge interval of any FDA-approved DBS system, necessitating only 10 recharge sessions a year for most people, and incorporates the NeuroSphere Virtual Clinic to allow patients to communicate with their doctors and receive treatment adjustments from their homes.
Deep Brain Stimulation In Parkinson`s Disease Market Key Players And Strategic Industry Positioning
Major companies operating in the deep brain stimulation in parkinson`s disease market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Mayo Foundation for Medical Education and Research, Cleveland Clinic, Renishaw plc, Neuralink Corp., NeuroPace Inc., PINS Medical Co. Ltd., Neurosoft Ltd., BrainsWay Ltd., Medscape, Inomed Medizintechnik GmbH, SceneRay Corporation Ltd., Neuroelectrics Barcelona S.L., Soterix Medical Inc., CorTec GmbH, Aleva Neurotherapeutics SA, NeuroSigma Inc., BrainGate Company Inc.
Access The Complete Deep Brain Stimulation In Parkinson`s Disease Market Report:
Deep Brain Stimulation In Parkinson`s Disease Market Geographic Landscape: Which Region Dominates Industry Growth?
North America was the largest region in the deep brain stimulation in parkinson’s disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the deep brain stimulation in parkinson`s disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
